The main criterion is people's access to medicines, not numbers on paper! / The answer to these days' concerns in the pharmaceutical market Mohammad Hashemi in an interview with "Iran": While the central bank announced the removal of currency and real restrictions and the allocation of significant resources to large pharmaceutical manufacturers, the Food and Drug Organization states that supply stability is the most important evaluation indicator. Logistical problems and delays in the pharmaceutical companies' access to financial resources make production and import planning a serious challenge and threaten the continuity of patient care. The true assessment of the state of the drug market requires taking into account the changes in costs and the speed of foreign exchange payments to those active in the field so that the financial resources will lead directly to the abundance of drugs in the pharmacies. Read the full text here.